Oriola
0.925
EUR
-0.22 %
Corporate customer
OKDBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
7,647 following
Income statement
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,527.7 | 1,552.2 | 1,721.3 | 1,800.8 | 1,882.4 | 1,841.4 | 1,493.8 | 1,685.9 | 1,776.7 | 1,862.3 | 1,952.0 |
growth-% | 1.6 % | 10.9 % | 4.6 % | 4.5 % | -2.2 % | -18.9 % | 12.9 % | 5.4 % | 4.8 % | 4.8 % | |
EBITDA | 64.6 | 53.3 | 60.6 | 63.1 | 65.4 | 68.6 | 30.1 | 27.7 | 26.7 | 28.1 | 30.2 |
EBIT (adj.) | 39.9 | 34.4 | 20.5 | 21.0 | 26.3 | 34.5 | 16.7 | 21.8 | 24.0 | 25.5 | 27.0 |
EBIT | 37.8 | 19.5 | 15.3 | 20.4 | 20.5 | 40.2 | -5.3 | 14.1 | 16.0 | 17.5 | 19.0 |
Profit before taxes | 33.9 | 16.6 | 10.1 | 14.3 | 14.7 | 35.4 | -17.6 | 1.2 | 10.5 | 16.5 | 18.6 |
Net income | 25.9 | 10.8 | 8.0 | 11.3 | 11.3 | 27.4 | -20.7 | -0.5 | 8.2 | 13.8 | 15.7 |
EPS (adj.) | 0.15 | 0.14 | 0.07 | 0.07 | 0.09 | 0.12 | 0.01 | 0.04 | 0.08 | 0.11 | 0.12 |
growth-% | -8.5 % | -48.8 % | -9.6 % | 44.4 % | 26.9 % | -94.1 % | 434.6 % | 112.5 % | 38.5 % | 9.7 % | |
Dividend | 0.09 | 0.09 | 0.09 | 0.03 | 0.04 | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.10 |
Dividend ratio | 63.0 % | 151.9 % | 204.5 % | 48.2 % | 64.2 % | 39.7 % | -61.2 % | -3,085.9 % | 199.2 % | 131.9 % | 115.6 % |
Profitability and return on capital
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | 4.2 % | 3.4 % | 3.5 % | 3.5 % | 3.5 % | 3.7 % | 2.0 % | 1.6 % | 1.5 % | 1.5 % | 1.5 % |
EBIT-% (adj.) | 2.6 % | 2.2 % | 1.2 % | 1.2 % | 1.4 % | 1.9 % | 1.1 % | 1.3 % | 1.4 % | 1.4 % | 1.4 % |
EBIT-% | 2.5 % | 1.3 % | 0.9 % | 1.1 % | 1.1 % | 2.2 % | -0.4 % | 0.8 % | 0.9 % | 0.9 % | 1.0 % |
ROE | 5.7 % | 4.8 % | 6.9 % | 5.8 % | 12.4 % | -10.4 % | -0.3 % | 5.3 % | 9.1 % | 10.6 % | |
ROI | 6.2 % | 4.7 % | 5.0 % | 4.6 % | 10.2 % | -3.1 % | 3.1 % | 6.7 % | 9.6 % | 10.6 % |
Valuation
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Share price (EUR) | 2.67 | 2.17 | 2.10 | 1.90 | 2.01 | 1.72 | 0.92 | 0.93 | 0.93 | 0.93 | 0.93 |
Shares | 181.5 | 181.4 | 181.4 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 |
Market cap | 484.6 | 392.7 | 380.9 | 344.5 | 364.5 | 311.9 | 166.8 | 167.7 | 167.7 | 167.7 | 167.7 |
Enterprise value | 594.9 | 456.3 | 500.5 | 471.6 | 465.3 | 288.2 | 103.5 | 87.6 | 83.6 | 91.1 | 101.6 |
EV/S | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 |
EV/EBITDA | 9.2 | 8.6 | 8.3 | 7.5 | 7.1 | 4.2 | 3.4 | 3.2 | 3.1 | 3.2 | 3.4 |
EV/EBIT (adj.) | 14.9 | 13.2 | 24.5 | 22.5 | 17.7 | 8.4 | 6.2 | 4.0 | 3.5 | 3.6 | 3.8 |
EV/EBIT | 15.8 | 23.4 | 32.7 | 23.1 | 22.7 | 7.2 | - | 6.2 | 5.2 | 5.2 | 5.3 |
P/E (adj.) | 17.3 | 15.3 | 29.0 | 29.1 | 21.3 | 14.4 | 131.3 | 24.7 | 11.6 | 8.4 | 7.7 |
P/E | 18.7 | 36.6 | 47.8 | 30.6 | 32.3 | 11.4 | - | - | 20.5 | 12.2 | 10.7 |
P/B | 2.5 | 2.2 | 2.4 | 2.0 | 1.7 | 1.4 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 |
P/S | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Dividend yield | 3.4 % | 4.2 % | 4.3 % | 1.6 % | 2.0 % | 3.5 % | 7.6 % | 8.6 % | 9.7 % | 10.8 % | 10.8 % |
Equity ratio | 21.4 % | 19.3 % | 15.3 % | 14.5 % | 19.8 % | 23.5 % | 18.3 % | 16.9 % | 15.8 % | 15.5 % | 14.6 % |
Gearing ratio | 55.8 % | 35.8 % | 76.1 % | 74.9 % | 46.5 % | -10.5 % | -12.0 % | -21.8 % | -25.4 % | -20.8 % | -13.9 % |
Quarter data
Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24 | Q4/24e | 2024e | Q1/25e | Q2/25e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 386.5 | 1,493.8 | 375.1 | 439.5 | 424.4 | 446.9 | 1,685.9 | ||
EBITDA | 8.3 | 30.1 | 6.7 | 8.6 | 4.9 | 7.5 | 27.7 | ||
EBIT | 5.3 | -5.3 | 3.7 | 5.7 | 0.2 | 4.5 | 14.1 | ||
Profit before taxes | -0.8 | -17.6 | -2.0 | 2.8 | -2.2 | 2.5 | 1.2 | ||
Net income | -2.7 | -20.7 | -2.3 | 1.9 | -1.9 | 1.9 | -0.5 |